Does empirical treatment of community-acquired pneumonia with fluoroquinolones delay tuberculosis treatment and result in fluoroquinolone resistance in Mycobacterium tuberculosis? Controversies and solutions

The role of fluoroquinolones (FQs) as empirical therapy for community-acquired pneumonia (CAP) remains controversial in countries with high tuberculosis (TB) endemicity owing to the possibility of delayed TB diagnosis and treatment and the emergence of FQ resistance in Mycobacterium tuberculosis. Al...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Int J Antimicrob Agents
Hauptverfasser: Shen, Gwan-Han, Tsao, Thomas Chang-Yao, Kao, Shang-Jyh, Lee, Jen-Jyh, Chen, Yen-Hsu, Hsieh, Wei-Chung, Hsu, Gwo-Jong, Hsu, Yen-Tao, Huang, Ching-Tai, Lau, Yeu-Jun, Tsao, Shih-Ming, Hsueh, Po-Ren
Format: Artigo
Sprache:Inglês
Veröffentlicht: Elsevier B.V. and the International Society of Chemotherapy. 2012
Schlagworte:
Review
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC7127649/
https://ncbi.nlm.nih.gov/pubmed/22285045
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ijantimicag.2011.11.014
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge